4//SEC Filing
Chouinard Michel 4
Accession 0001477126-10-000006
CIK 0000885590other
Filed
Nov 9, 7:00 PM ET
Accepted
Nov 10, 6:10 PM ET
Size
8.1 KB
Accession
0001477126-10-000006
Insider Transaction Report
Form 4
Chouinard Michel
COO, Biovail Labs.Int'l SRL
Transactions
- Exercise/Conversion
Restricted Share Units
2010-11-08−51,329→ 0 totalFrom: 2010-11-08Exp: 2014-08-05→ Common Shares, no par value (51,329 underlying) - Exercise/Conversion
Common Shares, no par value
2010-11-08+102,658→ 105,128 total
Footnotes (2)
- [F1]Each Restricted Share Unit ("RSU") represents a contingent right to receive one common share, no par value, of Valeant Pharmaceuticals International, Inc. and is subject to performance based vesting criteria, providing for vesting ranging from zero (0) to two hundred percent (200%).
- [F2]Represents performance based RSUs that accelerated at 200% in connection with the merger between the issuer (formerly known as Biovail Corporation) and Valeant Pharmaceuticals International and vested following the completion of the issuer's blackout period restrictions on November 8, 2010.
Documents
Issuer
Valeant Pharmaceuticals International, Inc.
CIK 0000885590
Entity typeother
Related Parties
1- filerCIK 0001479927
Filing Metadata
- Form type
- 4
- Filed
- Nov 9, 7:00 PM ET
- Accepted
- Nov 10, 6:10 PM ET
- Size
- 8.1 KB